Importantly, insulin should never be abruptly reduced or stopped when starting a GLP-1 receptor agonist, as this could lead to diabetic ketoacidosis
Sometimes a medicine is essential, and any psychological reactions it causes can be handled with another medication
Common Side Effects (Affecting 10-20% of Users) Vomiting affects 17% of users, decreased appetite beyond the therapeutic effect occurs in 16%, injection site reactions in 14%, fatigue in 13%, indigestion in 12%, and headaches in 11%
Clinical studies show that these are quite common, especially as the dosage increases
Wang et al., 2011), the present studies add to the growing data indicating that enhanced microbial production of TMA and subsequently, TMAO, fosters a pro-atherogenic phenotype